Assessment of choroidal topographic changes by swept-source optical coherence tomography after intravitreal ranibizumab for exudative age-related macular degeneration

American Journal of Ophthalmology

Volumn 160, Issue 5, 2015, Pages 1006-1013

  Razavi, Sam ^a,b   Souied, Eric H ^b   Darvizeh, Fatemeh ^c   Querques, Giuseppe ^b,c  

^a Transparency Eye Clinic   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

A SCAN; ADULT; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; B SCAN; CHOROID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FUNDUS CAMERA; HUMAN; LOADING DRUG DOSE; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA LUTEA; SUBRETINAL NEOVASCULARIZATION; TOPOGRAPHY; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; VERY ELDERLY; VISUAL ACUITY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; CHOROID; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RANIBIZUMAB; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84948716434     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2015.08.009     Document Type: Article

References (22)

1. N.M. Bressler Age-related macular degeneration is the leading cause of blindness JAMA 291 15 2004 1900 1901
2. J.D. Gass Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes Am J Ophthalmol 118 3 1994 285 298
3. D.M. De Bruin, D.L. Burnes, J. Loewenstein, and et al. In vivo three-dimensional imaging of neovascular age-related macular degeneration using optical frequency domain imaging at 1050 nm Invest Ophthalmol Vis Sci 49 10 2008 4545 4552
4. B. Potsaid, B. Baumann, D. Huang, and et al. Ultrahigh speed 1050nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second Opt Express 18 19 2010 20029 20048
5. Y. Yasuno, Y. Hong, S. Makita, and et al. In vivo high-contrast imaging of deep posterior eye by 1-micron swept source optical coherence tomography and scattering optical coherence angiography Opt Express 15 10 2007 6121 6139
6. M. Hirata, A. Tsujikawa, A. Matsumoto, and et al. Macular choroidal thickness and volume in normal subjects measured by swept-source optical coherence tomography Invest Ophthalmol Vis Sci 52 8 2011 4971 4978
7. S. Razavi, E.H. Souied, E. Cavallero, M. Weber, and G. Querques Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy Am J Ophthalmol 157 4 2014 852 860
8. S. Kuroda, Y. Ikuno, Y. Yasuno, and et al. Choroidal thickness in central serous chorioretinopathy Retina 33 2 2013 302 308
9. M. Adhi, and J.S. Duker Optical coherence tomography-current and future applications Curr Opin Ophthalmol 24 3 2013 213 221
10. S.E. Chung, S.W. Kang, J.H. Lee, and Y.T. Kim Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration Am J Ophthalmol 152 4 2011 663 668
11. V. Manjunath, J. Goren, J.G. Fujimoto, and J.S. Duker Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography Am J Ophthalmol 152 4 2011 663 668
12. L. Branchini, C. Regatieri, M. Adhi, and et al. Effect of intravitreous anti-vascular endothelial growth factor therapy on choroidal thickness in neovascular age-related macular degeneration using spectral-domain optical coherence tomography JAMA Ophthalmol 131 5 2013 693 694
13. K. Mazaraki, H. Fassnacht-Riedele, R. Blum, M. Becker, and S. Michels Change in choroidal thickness after intravitreal aflibercept in pretreated and treatment-naive eyes for neovascular age-related macular degeneration Br J Ophthalmol 2015 10.1136/bjophthalmol-2015-306636
14. E.C. McDonnell, F.M. Heussen, H. Ruiz-Garcia, and et al. Effect of anti-VEGF treatment on choroidal thickness over time in patients with neovascular age-related macular degeneration Eur J Ophthalmol 24 6 2014 897 903
15. C. Framme, G. Panagakis, and R. Birngruber Effects on choroidal neovascularization after anti-VEGF upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography Invest Ophthalmol Vis Sci 51 3 2010 1671 1676
16. A.A. Ellabban, A. Tsujikawa, K. Ogino, and et al. Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization Clin Ophthalmol 6 2012 837 844
17. J.B. Jonas, T.M. Forster, P. Steinmetz, F.C. Schlichtenbrede, and B.C. Harder Choroidal thickness in age-related macular degeneration Retina 34 6 2014 1149 1155
18. T. Yamazaki, H. Koizumi, T. Yamagishi, and S. Kinoshita Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results Ophthalmology 119 8 2012 1621 1627
19. J.H. Kim, Y.S. Chang, T.G. Lee, and C.G. Kim Choroidal vascular hyperpermeability and punctate hyperfluorescent spot in choroidal neovascularization Invest Ophthalmol Vis Sci 56 3 2015 1909 1915
20. S. Sizmaz, C. Kucukerdonmez, A. Kal, E.Y. Pinarci, H. Canan, and G. Yilmaz Retinal and choroidal thickness changes after single anti-VEGF injection in neovascular age-related macular degeneration: ranibizumab vs bevacizumab Eur J Ophthalmol 24 6 2014 904 910
21. H. Koizumi, M. Kano, A. Yamamoto, and et al. Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration Am J Ophthalmol 159 4 2015 627 633
22. K. Mansouri, F.A. Medeiros, N. Marchase, A.J. Tatham, D. Auerbach, and R.N. Weinreb Assessment of choroidal thickness and volume during the water drinking test by swept-source optical coherence tomography Ophthalmology 120 12 2013 2508 2516